JFL Life Sciences Limited SME IPO – NSE Emerge opens on 25th August 2022; Intends to raise Rs 1,816.58 Lakhs through 29,78,000 equity shares

August 26: JFL Life Sciences Limited, engaged in the business of manufacturing pharmaceutical products having experience of more than a decade, is all set to raise Rs 1,816.58 Lakhs through an initial public offering (IPO). The issue opens on the 25th of August and will be listed on NSE Emerge.

The public issue of JFL Life Sciences Limited is of 29,78,000 equity shares of Face Value ₹10 each (“EQUITY SHARES”) for cash at a price of ₹ 61/- per equity share (including a securities premium of ₹ 51/- per equity share) (the issue price) aggregating ₹ 1,816.58 LACS of the issue. 1,50,000 equity shares aggregating to ₹ 91.50 Lakhs will be reserved for market maker (“Market Maker Reservation Portion”). The issue, less the Market Maker Reservation Portion, i.e., issue of 28,28,000 equity shares of Face Value of ₹ 10/- EACH at an issue price of ₹ 61/- per equity share, aggregating to ₹ 1,725.08 Lakhs, which is hereinafter referred to as “The Net Issue”. The issue and the Net Issue will constitute 27.08% AND 25.71%, respectively of the post issue paid up equity share capital of the company. The company will list at NSE Emerge. The Lead manager of the issue is GYR Capital Advisors Pvt Ltd and the Registrar to the issue is KFin Technologies Ltd. The issue opens on the 25th of August and will close on the 30th of August, 2022 and will subsequently be listed on NSE Emerge.

The company intends to utilize the proceeds of the Issue to meet the following objectives:

  1. Repayment of secured and unsecured loans
  2. Funding the working capital requirements of the company
  3. General Corporate Purposes

JFL Life Sciences Limited is engaged in the business of manufacturing pharmaceutical products. Their product portfolio consists of Dry powder injections (B-Lactam), Tablets & Capsules (B-Lactam) solid oral dosage form and Tablet and capsules (general) Solid Oral Dosage Form and Oral rehydration solutions (ORS). With market presence in pan India, products of JFL supplies to 10 developed and developing countries throughout the World. To maintain its competitiveness and to further the cause of health care JFL has laid a strong R&D foundation and an FDA approved state of the art manufacturing facility near Ahmedabad.

The Company has registered their products to manufacture in various countries like sovereign of Kenya, Nigeria, Yemen & Myanmar. Few of their products are also registered with Ukraine, Uzbekistan, and Kazakhstan as well. This also makes them a ‘one-stop-shop’ service provider for catering to all of the customer’s needs domestically as well as internationally.

The promoters, Mr. Smiral Ashwinbhai Patel and Tejal Smiralbhai Patel are actively involved in the day-to-day business of the company and are the guiding force behind the strategic decisions for the Company. Their management team and other key management personnel are well qualified and have extensive industry expertise, and have been responsible for the operational growth.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

BIG BOX announces Series A Funding From Top Public Listed Company

BIG BOX Ventures Private Limited New Delhi (India), January 30: BIG BOX Ventures Private Limited (BIG BOX), a Pune-based managed workspace solution provider, has received a multi-million-dollar investment from a top publicly listed company for a minority stake. BIG BOX will use the funds to enter new markets and increase its presence at several new centres […]

Read More
Business

After Gandhi Godse – Ek Yudh, Producer Jhoolan Prasad Gupta is soon coming up with new OTT Fun Prime Entertainment

Jhoolan Prasad Gupta & Rajkumar Santoshi New Delhi (India), January 30: JP Gupta (Jhoolan Prasad Gupta) has proved his struggle and success story in a new form and everywhere. Jhoolan Prasad Gupta is co-producer of National Film Award-winning director Rajkumar Santoshi’s film Gandhi Godse – Ek Yudh. Jhoolan Prasad Gupta has emerged as a personality. […]

Read More
Business

MOLD-TEK TECHNOLOGIES LIMITED Announces Q3 2022-23, PAT up by 5.5 times from ` 1.67 Cr in Q3 2021-22 to `9.21 Cr

PAT up by 5.5 times from ` 1.67 Cr in Q3 2021-22 to ` 9.21 Cr in Q3 2022-23 Consolidated Profit after Tax 9M on 9M up by 122.96% Consolidated Sales 9M on 9M up by 48.98% Hyderabad (Telangana) [India], January 30: Mold-Tek Technologies Limited, KPO in Structural Engineering and Designing services posted excellent financial results for the Quarter and Nine months ended 31st December 2022 in […]

Read More